634 related articles for article (PubMed ID: 15563743)
1. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale.
Argoff CE; Galer BS; Jensen MP; Oleka N; Gammaitoni AR
Curr Med Res Opin; 2004; 20 Suppl 2():S21-8. PubMed ID: 15563743
[TBL] [Abstract][Full Text] [Related]
2. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain.
Galer BS; Gammaitoni AR; Oleka N; Jensen MP; Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S5-12. PubMed ID: 15563741
[TBL] [Abstract][Full Text] [Related]
3. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale.
Gammaitoni AR; Galer BS; Onawola R; Jensen MP; Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S13-9. PubMed ID: 15563742
[TBL] [Abstract][Full Text] [Related]
4. Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale.
Argoff CE
Curr Med Res Opin; 2004; 20 Suppl 2():S29-31. PubMed ID: 15563744
[TBL] [Abstract][Full Text] [Related]
5. Introduction: chronic pain studies of the lidocaine patch 5% using the Neuropathic Pain Scale.
Jensen MP
Curr Med Res Opin; 2004; 20 Suppl 2():S1-4. PubMed ID: 15563740
[TBL] [Abstract][Full Text] [Related]
6. Lidocaine 5% patch: an open-label naturalistic chronic pain treatment trial and prediction of response.
Fishbain DA; Lewis JE; Cole B; Cutler B; Rosomoff HL; Rosomoff RS
Pain Med; 2006; 7(2):135-42. PubMed ID: 16634726
[TBL] [Abstract][Full Text] [Related]
7. Lidocaine patch 5 for carpal tunnel syndrome: how it compares with injections: a pilot study.
Nalamachu S; Crockett RS; Mathur D
J Fam Pract; 2006 Mar; 55(3):209-14. PubMed ID: 16510054
[TBL] [Abstract][Full Text] [Related]
8. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy.
Herrmann DN; Barbano RL; Hart-Gouleau S; Pennella-Vaughan J; Dworkin RH
Pain Med; 2005; 6(5):379-84. PubMed ID: 16266359
[TBL] [Abstract][Full Text] [Related]
9. Lidocaine patch 5% reduces pain intensity and interference with quality of life in patients with postherpetic neuralgia: an effectiveness trial.
Katz NP; Gammaitoni AR; Davis MW; Dworkin RH;
Pain Med; 2002 Dec; 3(4):324-32. PubMed ID: 15099237
[TBL] [Abstract][Full Text] [Related]
10. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
11. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale.
Galer BS; Jensen MP; Ma T; Davies PS; Rowbotham MC
Clin J Pain; 2002; 18(5):297-301. PubMed ID: 12218500
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
[TBL] [Abstract][Full Text] [Related]
13. Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale.
Jensen MP; Dworkin RH; Gammaitoni AR; Olaleye DO; Oleka N; Galer BS
J Pain; 2005 Feb; 6(2):98-106. PubMed ID: 15694876
[TBL] [Abstract][Full Text] [Related]
14. Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies.
Herrmann DN; Pannoni V; Barbano RL; Pennella-Vaughan J; Dworkin RH
Muscle Nerve; 2006 Jan; 33(1):42-8. PubMed ID: 16228968
[TBL] [Abstract][Full Text] [Related]
15. Topical lidocaine gel relieves postherpetic neuralgia.
Rowbotham MC; Davies PS; Fields HL
Ann Neurol; 1995 Feb; 37(2):246-53. PubMed ID: 7847866
[TBL] [Abstract][Full Text] [Related]
16. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain.
White WT; Patel N; Drass M; Nalamachu S
Pain Med; 2003 Dec; 4(4):321-30. PubMed ID: 14750908
[TBL] [Abstract][Full Text] [Related]
17. [Lidocaine tape (Penles--a dressing tape based on 60% lidocaine--) reduces the pain of postherpetic neuralgia].
Tamakawa S; Ogawa H
Masui; 1998 Jul; 47(7):882-4. PubMed ID: 9720343
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-masked, placebo-controlled pilot trial of extended IV lidocaine infusion for relief of ongoing neuropathic pain.
Tremont-Lukats IW; Hutson PR; Backonja MM
Clin J Pain; 2006; 22(3):266-71. PubMed ID: 16514327
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy.
Barbano RL; Herrmann DN; Hart-Gouleau S; Pennella-Vaughan J; Lodewick PA; Dworkin RH
Arch Neurol; 2004 Jun; 61(6):914-8. PubMed ID: 15210530
[TBL] [Abstract][Full Text] [Related]
20. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study.
Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M
Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
